Multiplikator Forward P/S: Profound Medical Corp (PROF)
Profound Medical Corp. (PROF) is scaling the deployment of TULSA-PRO systems by expanding insurance coverage in the US. This chart from the GURU.Markets terminal illustrates market expectations via the projected P/S metric, while 11.60 represents the current level of the metric. Growth is driven by MRI-therapy patents and recurring sales of consumables, which will facilitate global market share capture through B2B supplies to urological centers.
Ringkesan rincian data analitis profoundmedical.com (PROF)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Profound Medical Corp.|PROF - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Profound Medical|PROF - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Profound Medical Corp.|PROF - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Profound Medical|Rasio cepet profoundmedical.com
- rincian asil keuangan lan kelipatan valuasi:
PROF - Penghasilan resik perusahaan|Bathi sing dikarepake Profound Medical Corp.|PROF - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Profound Medical|PROF - Pangali PEG|Pangali EV/EBITDA Profound Medical Corp.|PROF - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Profound Medical|PROF - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan profoundmedical.com|PROF - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Profound Medical Corp.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:PROF (Profound Medical Corporation)
Profound Medical Corp. maintains its leadership in non-invasive prostate cancer therapy due to the high level of trust urologists place in its MRI systems. GURU.Markets analysts utilize the forward P/S multiple to assess the ratio of market value to projected revenue, accounting for tax incentives, which allows them to determine the business's margin of safety and the risk of overpaying for the issuer's innovative potential.
Karo sapa Profound Medical Corp. saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (SANUWAVE Health, Inc.) - Multiplikator forward rega marang pendapatan|Outset Medical Corp - Rega forward marang dodolan|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep lensar.com LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical (RCEL)|bairdmed.com (BDMD) - Prakiraan rega marang pendapatan|EDAP TMS - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Apyx Medical Corp APYX|IceCure Medical, Ltd. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Pulmonx Corporation LUNG|telabio.com (TELA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CTSO (CytoSorbents Corporation)|Rasio rega marang prakiraan pendapatan Sensus Healthcare Corp|Multiplikator forward rega marang pendapatan Zynex Corp (ZYXI)|Multiplikator Forward P/S ECOR|RBOT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Inspira Technologies IINN|ICU: Kapitalisasi marang prakiraan pendapatan|IRIX: Multiplikator forward rega marang pendapatan|Intelligent Bio Solutions - Rasio rega marang pendapatan sing dikarepake|beyondair.net (XAIR) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan PFSA (profusa.com)|Rasio rega marang prakiraan pendapatan STRATA Skin Sciences Inc.|GCTK: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan NanoVibronix (NAOV)|VERO - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S NUWE (Nuwellis, Inc.)|AEMD (aethlonmedical.com) - Rega mangsa ngarep marang pendapatan|ASXC - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Avinger Inc.|BSGM (BioSig Technologies, Inc) - Multiplikator forward rega marang pendapatan|Cutera Inc (CUTR) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Know Labs, Inc.|Kapitalisasi marang prakiraan pendapatan NARI (inarimedical.com)|Multiplikator Forward P/S NVRO|reshapelifesciences.com - Kapitalisasi marang prakiraan pendapatan|Silk Road Medical Inc. - Multiplikator forward rega marang pendapatan
